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 Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells by the transcription factors Oct4, 
Sox2, and Klf4 in combination with c-Myc. Recently, Sox2 plus Oct4 was shown to reprogram fibroblasts and Oct4 
alone was able to reprogram mouse and human neural stem cells (NSCs) into iPS cells. Here, we report that Bmi1 
leads to the transdifferentiation of mouse fibroblasts into NSC-like cells, and, in combination with Oct4, can replace 
Sox2, Klf4 and c-Myc during the reprogramming of fibroblasts into iPS cells. Furthermore, activation of sonic hedge-
hog signaling (by Shh, purmorphamine, or oxysterol) compensates for the effects of Bmi1, and, in combination with 
Oct4, reprograms mouse embryonic and adult fibroblasts into iPS cells. One- and two-factor iPS cells are similar to 
mouse embryonic stem cells in their global gene expression profile, epigenetic status, and in vitro and in vivo differ-
entiation into all three germ layers, as well as teratoma formation and germline transmission in vivo. These data sup-
port that converting fibroblasts with Bmi1 or activation of the sonic hedgehog pathway to an intermediate cell type 
that expresses Sox2, Klf4, and N-Myc allows iPS generation via the addition of Oct4.
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Introduction
The potential of induced pluripotent stem (iPS) cell 
technology is enormous, but comprehension of the mo-
lecular mechanisms that underlie reprogramming is mea-
ger, largely because the procedure is still very inefficient. 
Recently, a number of groups have demonstrated that the 
inactivation of p53 markedly increases the efficiency of 
iPS cell generation [1-6]. Furthermore, by reducing the 
expression of both p16Ink4a and p19Arf (both of which are 
encoded by alternative reading frames of the Ink4a/Arf 
locus, also known as the Cdkn2a locus), iPS cell forma-
tion was increased relative to that achieved by reducing 
the expression of p19Arf alone.
Bmi1 was first identified as a proto-oncogene that co-
operates with c-Myc to promote the formation of B- and 
T-cell lymphomas [7, 8] by inhibiting c-Myc-induced 
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apoptosis through repression of the Ink4a/Arf locus [9, 
10]. Bmi1 is also required for the self-renewal of stem 
cells and the Ink4a/Arf locus is the main target of Bmi1 
stem cell proliferation activity [11-13]. Furthermore, ac-
tivation of the sonic hedgehog (Shh) signaling pathway 
induces Bmi1, Sox2, and N-Myc expression, resulting 
in increased proliferation of neural precursors [14-16]. 
In this study, we hypothesized that cells with reduced 
expression of p16Ink4a and p19Arf as well as increased N-
Myc, Klf4, and Sox2 expression [13, 16] mediated by 
Bmi1 overexpression could be efficiently converted into 
iPS cells with either two factors (Oct4 and Sox2: hereaf-
ter designated as 2F-Bmi1-iPS cells (OSB)) or only one 
factor (Oct4: hereafter designated as BO-iPS cells). Fur-
thermore, we also asked whether Shh or activation of the 
Shh signaling pathway by oxysterol or purmorphamine 
can regulate the downstream target genes of Bmi1 in 
the generation of BO-iPS cells. Our study demonstrates 
that Bmi1 has dual effects on iPS cell generation from 
fibroblasts by both suppressing p16 Ink4a and p19 Arf and 
augmenting Sox2 and N-Myc. By inducing Bmi1 with 
some chemicals, we have also shown that only one 
transcription factor (Oct4) is required to reprogram fi-
broblasts into pluripotent cells, which have the ability to 
differentiate into all three germ layer cell types and are 
capable of germline transmission.
Results
Bmi1 replaces the function of Klf4 and c-Myc, and 
increases reprogramming efficiency
Considering that Bmi1 is essential for the self-renewal 
of stem cells through repression of the p53 and Rb path-
ways, we investigated whether Bmi1 could enhance the 
reprogramming of fibroblasts into iPS cells. To answer 
this question, we first determined the expression levels 
of reprogramming-related genes (p16Ink4a, p19Arf, Sox2, 
N-Myc, p53, and Klf4) in parental mouse embryonic 
fibroblasts (MEFs) and Bmi1-transduced cells. p16Ink4a, 
p19Arf, and p53 were significantly repressed in Bmi1-
transduced cells compared to MEFs; however, consistent 
with a previous report [16], Sox2, N-Myc, and Klf4 
were abundantly expressed (Figure 1A and 1B). Next, 
we tested whether Bmi1 could replace Oct4, Sox2, Klf4, 
or C-Myc. The four transcription factors (Oct4, Sox2, 
Klf4, and C-Myc; OSKM) or a combination of three 
of the transcription factors with Bmi1 (OSKB, OSBM, 
OBKM, and BSKM) were introduced into MEFs. Bmi1 
was able to replace Sox2, Klf4, or C-Myc in inducing 
Nanog-positive colonies that resemble embryonic stem 
(ES) cells (Figure 1C and Supplementary information, 
Figure S1). However, we found that in the absence of 
Oct4, Nanog positive colonies were not formed (data not 
shown), indicating that Bmi1 is not able to replace Oct4 
for reprogramming MEFs. We also tested whether Bmi1 
was able to replace both Klf4 and C-Myc (Figure 1A). 
We reprogrammed mouse fibroblasts with Oct4 and Sox2 
or with the two factors plus Bmi1 (2F-Bmi1-iPS (OSB)). 
Overexpression of Bmi1 in these two-factor experiments 
increased the number of Nanog-positive colonies, con-
sistent with a role of Bmi1 as a replacement for Klf4 and 
C-Myc, as well as a limited role in regulating the p53 
and Rb pathways during reprogramming. The OSB colo-
nies were very similar to those comprised of mouse ES 
cells and expressed pluripotency-associated transcription 
factors as well as pluripotent cell surface markers (Figure 
1D and Supplementary information, Figure S1). Taken 
together, these data suggest that Bmi1-mediated regula-
tion of N-Myc, Klf4, p16Ink4a, and p19Arf activity mark-
edly increases reprogramming efficiency.
Induction of fibroblasts into iPS cells with Bmi1 plus 
Oct4
Methods designed to reduce the number of factors 
necessary for reprogramming have taken advantage of 
endogenously expressed reprogramming factors such as 
Sox2 [17]. For example, studies show that adult mouse 
neural stem cells (NSCs), which exhibit endogenous 
Sox2 expression, can be reprogrammed by Oct4 alone [17, 
18]. However, methods reprogramming somatic cells 
that lack endogenous Sox2 expression to pluripotency 
with Oct4 alone need to be explored. Based on previ-
ous results [16], we hypothesized that cells transduced 
by Bmi1 could be transdifferentiated into NSC-like 
cells and then converted into iPS cells by Oct4 (Figure 
2A left panel). We first determined whether Bmi1 could 
transdifferentiate MEFs into NSC-like cells. Bmi1-
transduced MEFs, but not empty vector-transduced 
MEFs, formed colonies exhibiting an NSC-like morphol-
ogy within 3-7 days in NSC culture (Figure 2A and 2B). 
Of the 45 colonies generated, four were selected and 
grown using standard mouse NSC culturing methods. 
All four selected colonies expressed genes and cell sur-
face markers characteristic of mouse NSCs, including 
Nestin and Sox2, as well as AP activity (Figure 2C). In 
addition, Bmi1-transduced spheres gave rise to neurons, 
oligodendrocytes, and astrocytes (Figure 2D). Next, we 
investigated whether Bmi1-transduced NSC-like cells 
could be reprogrammed into iPS cells by transduction 
with Oct4 alone. Indeed, we succeeded in generating ES-
like colonies within 10-14 days. We refer to these repro-
grammed cells as transdifferentiated BO-iPS cells (dBO-
iPS cells). These cells were generated from MEFs that 
were first transdifferentiated into NSC-like cells and then 
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further reprogrammed into iPS cells (Figure 2E). We also 
determined whether Bmi1 could replace Sox2, Klf4, and 
C-Myc and, in combination with Oct4, reprogram MEFs 
into iPS cells (Figure 2A right panel). We introduced 
Bmi1 and Oct4 into MEFs and were able to induce the 
formation of ES-like cells, hereafter designated as BO-
iPS cells. The estimated reprogramming efficiency was 
calculated at 0.01% and 0.17% for dBO- and BO-iPS 
cells, respectively. The reprogramming efficiency of 
dBO-iPS cells was approximately 6% of that obtained 
Figure 1 Increased generation of iPS cells by overexpression of Bmi1. (A) Hypothesis of Bmi1’s function in the course of re-
programming. (B) MEFs were infected with a retrovirus encoding Bmi1 or an empty vector. Three days after infection, protein 
levels of Bmi1, p16Ink4a, p19Arf, and Sox2 were analyzed by western blot. Actin was used as a loading control. (C) Reprogram-
ming efficiencies of factor combinations on iPS cell induction. Bmi1 replaces Sox2, Klf4, and C-Myc in the reprogramming of 
MEFs. Reprogramming efficiency was quantified by determining the percentage of Nanog-positive colonies. (D) MEFs were 
infected with retroviruses encoding two factors (Oct4 and Sox2; OS) or with the two factors plus Bmi1 (OSB). Seven days af-
ter infection, Nanog-positive colonies formed from cells infected with OSB, but not OS (left and lower panel). Scale bars, 200 
µm. Protein levels of Oct4, Sox2, c-Myc, Klf4, and p53 were analyzed by western blot. α-tubulin was used as a loading control 
(right panel).
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Figure 2 Characterization of iPS cells generated from MEFs by retroviral transduction with Oct4 and Bmi1. (A) Hypothesis 
of Bmi1’s function in the course of reprogramming MEFs into dBO- (left) and BO-iPS cell (right). (B) Phase contrast images 
of vehicle- (upper) and Bmi1-transduced (lower) MEFs cultured in proliferation medium (left) and in NSC medium (right). 
Bmi1-transduced MEFs cultured in NSC medium for 3-7 days rapidly changed morphology, resulting in bipolar and expanded 
NSC-like cells (right). Scale bars, 200 µm. (C) Characterization of NSC-like cells was conducted by AP staining and immuno-
cytochemistry for Nestin and Sox2, as well as RT-PCR analysis of NSC marker genes (right). Scale bars, 200 µm. (D) NSC-
like cells exhibit multipotency and thus can give rise to cells expressing neuronal and glial markers for oligodendrocytes (O4, 
CNPase, and GalC), neurons (Tuj1 and Map2a), and astrocytes (GFAP and S100). Scale bars, 200 µm. (E) Phase contrast 
images showing mES cells (upper left) and BO-iPS cells (clone 1; lower left) on feeder cells. The reprogramming efficiency of 
dBO- and BO-iPS cells was quantified by determining the percentage of Nanog-positive colonies (right). (F) Characterization 
of BO-iPS-1 cells. AP staining, as well as SSEA1, Oct4, Sox2, and Nanog immunoreactivities, were measured in mES cells 
(upper panels) and BO-iPS cells (lower panels). Scale bars, 200 µm. (G) Scatter plots of the global gene expression compar-
ing BO-iPS cells with MEFs (right) and BO-iPS cells with mES cells (left). Red and green lines indicate 2-fold changes in gene 
expression levels. The pluripotency genes Oct4, Sox2, Nanog, c-Myc, and Klf4 are shown in red. (H) Bisulfite genomic se-
quencing of Oct4 and Nanog promoter regions in mES cells, MEFs, and BO-iPS clones (1, 2, and 3). Open and filled circles 
indicate unmethylated and methylated CpG dinucleotides, respectively.
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by BO-iPS cells. The reason for the lower reprogram-
ming efficiency of dBO-iPS than BO-iPS cells is not 
clear; however, it may be due to the poor transduction 
efficiency of Oct4 into the NSC-like spheres. To further 
characterize the BO-iPS cells, six colonies that were 
morphologically indistinguishable from mouse ES (mES) 
cell colonies were selected and grown under standard 
conditions (Figure 2E). BO-iPS cells expressed marker 
genes at levels typical of mES cells (Figure 2F and Sup-
plementary information, Figures S2A, B, and S3A, B). 
Furthermore, scatter plots of the global gene expression 
profiles showed that the BO-iPS cell profile was similar 
to mES cells and was different from MEFs (Figure 2G). 
To further compare BO-iPS cells with mES cells, the 
methylation state of CpG dinucleotides in the Oct4 and 
Nanog promoter regions was analyzed. Bisulfite genomic 
sequencing analyses showed that the Oct4 and Nanog 
promoter regions were demethylated in BO-iPS cells 
relative to the parental fibroblasts and showed a similar 
pattern to that of mES cells (Figure 2H). Chromatin im-
munoprecipitation (ChIP) analyses showed that the Oct4, 
Sox2, and Nanog promoters had increased acetylation 
of histone H3 (AcH3) and decreased dimethylation of 
lysine 9 of histone H3 (diMeK9H3) (Supplementary in-
formation, Figure S2C), consistent with the epigenetic 
remodeling that occurs during reprogramming. Oct4 
mRNA was transcribed from the endogenous Oct4 locus, 
which can be distinguished from the virally expressed 
human Oct4. Genomic integration of the Bmi1 and Oct4 
transgenes was confirmed (Supplementary information, 
Figure S3C), and the expression of both transgenes was 
efficiently silenced in all iPS cell lines examined (Sup-
plementary information, Figure S3D) [19].
We next investigated the differentiation potential of 
BO-iPS cells in vitro with the embryoid body (EB) as-
say. EBs derived from BO-iPS cells expressed markers 
of the three germ layers, including the endoderm marker 
GATA4, the mesoderm markers smooth muscle actin 
and Brachyury, and the ectoderm marker Nestin (Figure 
3A). To investigate the differentiation potential of BO-
iPS cells in vivo, we analyzed teratomas that formed after 
subcutaneous injection of BO-iPS cells into nude mice. 
These teratomas contained derivatives of the three em-
bryonic germ layers, including neural epithelium, mus-
cle, cartilage, and various glandular structures (Figure 3B 
and Supplementary information, Figure S3E). To assess 
their developmental potential, we tested whether BO-
iPS cells could generate chimeric mice after injection 
into blastocysts. According to coat color, BO-iPS clones 
generated chimeric mice with germline transmission 
(Figure 3C). Taken together, these results demonstrate 
that Bmi1 can either transdifferentiate MEFs into NSC-
like cells and/or replace Sox2, Klf4, and C-Myc during 
reprogramming of MEFs into iPS cells in the presence 
of Oct4. In addition, our results suggest that chemically 
induced activation of Bmi1 may be a useful strategy for 
enhancing reprogramming efficiency without genetic 
manipulation of the potential oncogenic Bmi1.
Shh induces Bmi1 and stimulates the generation of iPS 
cells from fibroblasts by transduction with Oct4 alone
Shh, the most prominent member of the Hedgehog 
family, plays an essential role during development. The 
Shh signaling pathway involves the activation of Gli 
transcription factors, which regulate the transcription 
of target genes including Gli1 and Ptch1. Furthermore, 
Bmi1, Sox2, and N-Myc expression was upregulated in 
response to Shh treatment and parallels the expression of 
Gli1, suppressor of fused (Sufu), and cyclin D2, which 
is indicative of the activation of the Shh pathway and in-
duction of proliferation [14-16, 20, 21]. Moreover, over-
expression of Gli1 induces Bmi1 expression, suggesting 
that Bmi1 is a downstream target in the Shh pathway [15].
Therefore, we tested whether Shh could replace Bmi1 
in the generation of dBO- and BO-iPS cells. Bmi1, Sox2, 
N-Myc, Klf4, and Gli1 mRNAs were upregulated (in 
contrast to p16Ink4a and p19Arf mRNAs, which were sup-
pressed) in response to Shh treatment as early as 72 h 
after incubation, indicating the activation of the Shh 
pathway (Figure 4A and 4B). Moreover, cells developed 
into colonies exhibiting an NSC-like morphology within 
3-7 days of Shh treatment in standard NSC culture condi-
tions (Figure 4C). These NSC-like cells expressed genes 
and cell surface markers characteristic of mouse NSCs, 
including Sox2, Nestin, and SSEA1, as well as AP activ-
ity (Figure 4D). Shh-treated NSC-like cells were then 
transduced with Oct4 to reprogram them into iPS cells 
(1F combination of Shh and Oct4, hereafter designated 
as ShO-iPS cells). ShO-iPS colonies obtained within 14 
days in culture were further analyzed by the same tests 
described above for BO-iPS cells to confirm reprogram-
ming to pluripotency (Figure 4E-F and Supplementary 
information, Figure S4). Taken together, these results 
demonstrate that Shh can induce Bmi1, and together with 
Oct4, can reprogram MEFs into iPS cells that are very 
similar to mES cells (Supplementary information, Figure 
S4I). 
Recently, it was demonstrated that specific oxysterol 
and purmorphamine not only stimulate the Shh pathway 
but also activate Shh target gene transcription through 
the protein Smo [22, 23]. Similar to ShO-iPS cells, treat-
ment of MEFs with either oxysterol or purmorphamine 
activated the Shh pathway, reprogramming MEFs into 
NSC-like cells that exhibited gene expression profiles 
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Figure 3 In vitro and in vivo differentiation of BO-iPS cells. (A) In vitro differentiation of BO-iPS cells. Micrographs show EBs 
generated from BO-iPS-1 clones and their in vitro differentiation into ectodermal, mesodermal, and endodermal cell types, 
as revealed by immunoreactivity to typical markers Nestin, Brachyury, SMA, and GATA4, respectively. Nuclei were counter-
stained with DAPI (blue). Scale bars, 200 µm. RT-PCR analysis shows that cDNAs from EBs exhibit expression of represen-
tative lineage markers in differentiating cells. (B) The in vivo developmental potential of BO-iPS cells. Teratomas generated 
by BO-iPS cells differentiated into neural rosettes (ectoderm), muscle and fat (mesoderm), and epithelium (endoderm). He-
matoxylin and eosin-stained sections of teratomas derived from BO-iPS cells in a nude mouse after 8-10 weeks are shown. 
Scale bars, 200 µm. (C) Chimeric mouse (upper panels) and germline contribution of BO-iPS cells in adult chimera gonads 
(lower panels). Established iPS cells give rise to live chimeras (upper left) after an injection of BO-iPS cells (Balb/c genetic 
background) into a C57BL6 blastocyst and contribute to the germline (lower left). PCR was performed on genomic DNA to 
detect exogenous and endogenous transgene integration in chimeric (upper right) and germline transmission mice (lower 
right) produced with BO-iPS cells.
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Figure 4 Generation and characterization of 1F ShO-iPS cells. (A) Hypothesis of induction of Bmi1 in the course of 
reprogramming. (B) Induction of sonic hedgehog target genes by Shh treatment. RT-PCR and qPCR of mRNAs from MEFs 
treated with vehicle (con) or Shh were analyzed for the induction of Shh target genes (Gli1, Bmi1, Sox2, and N-Myc, as well 
as p16Ink4a, p19Arf, and Klf4). Data are from a representative experiment (left) and are shown as the means and SD’s of rela-
tive values compared to control MEFs (n = 3). *P < 0.05 compared to MEFs. (C) Phase contrast images of vehicle- (shh(−)) 
and Shh-treated (shh(+)) MEFs cultured in proliferation medium (left) or NSC medium (right). Shh-treated MEFs cultured 
in NSC medium for 7 days rapidly changed morphology, resulting in bipolar (right) and expanded neurosphere-like cells 
(right). Scale bars, 200 µm. (D) Characterization of neurosphere-like morphology from Shh-treated MEFs was conducted by 
AP staining, immunocytochemistry, and RT-PCR for Nestin, Sox2, SSEA1, Musashi1, and CD133. Scale bars, 200 µm. (E) 
Timeline for ShO-iPS cell induction using Shh treatment with retroviral transduction of Oct4 (upper and left, panel). Phase 
contrast images showing the ESC-like morphology of ShO-iPS cells on feeder cells and the characterization of ShO-iPS 
cells. AP staining, as well as SSEA1, Oct4, Sox2, and Nanog immunoreactivity, was detected in ShO-iPS cells (lower panel). 
The reprogramming efficiency of BO- and ShO-iPS cells in reprogramming MEFs. Reprogramming efficiency was quantified 
by determining the percentage of Nanog-positive colonies. Scale bars, 200 µm (upper and right panel). (F) The in vivo devel-
opmental potential of ShO-iPS cells. Teratomas of ShO-iPS cells differentiated into epithelium (endoderm; left), muscle and 
fat (mesoderm; middle), and neural rosettes (ectoderm; right). Hematoxylin and eosin-stained sections of teratomas derived 
from ShO-iPS cells in a nude mouse host after 8 weeks are shown. Scale bars, 200 µm.
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characteristic of NSCs (Supplementary information, 
Figure S5A-S5C). Furthermore, the treatment of MEFs 
with oxysterol and/or purmorphamine enhanced the 
reprogramming of MEFs to pluripotency by the forced 
expression of Oct4 (1F combinations of oxysterol and/or 
purmorphamine and Oct4, hereafter designated as OxyO-
iPS, PO-iPS, or POxyO-iPS cells) (Supplementary in-
formation, Figure S5D). Again, the tests described above 
were successfully conducted with PO-iPS and OxyO-iPS 
cells (Supplementary information, Figures S5E-M and 
S6A-H). Furthermore, PO-iPS cells were germline com-
petent, as demonstrated by the generation of albino off-
spring from crossing chimeric mice with wild-type mice 
(Supplementary information, Figure S6I). These results 
demonstrate that MEFs can be reprogrammed to pluripo-
tency by Oct4 alone when the Shh pathway is activated.
Given that Bmi1 is an important regulator of repro-
gramming-related genes (Figure 1A and 1B) [13], the 
transdifferentiation of MEFs into NSC-like cells, and the 
generation of iPS cells with Oct4, we studied whether 
Figure 5 Decreased generation of iPS cells by the knockdown of Bmi1. (A, B) Inhibition of Bmi1 expression prevents neu-
rosphere formation. Scale bars, 200 µm. (C) qPCR analysis of Bmi1 target genes in vehicle and Bmi1 siRNA-transfected 
purmorphamine- or oxysterol-treated MEFs. *P < 0.05 compared to control. (D) The reprogramming efficiency of vehicle and 
Bmi1 siRNA-transfected POxyO-iPS cells in reprogramming MEFs. Reprogramming efficiency was quantified by determining 
the percentage of Nanog-positive colonies. (E) Model summarizing the presented data. Bmi1 and Bmi1 inducers (Shh, purmor-
phamine, and oxysterol) enhance Oct4-induced reprogramming of fibroblasts by downregulating p16Ink4a and p19Arf expression 
and upregulating Sox2, N-Myc, and Klf4 expression.
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knocking down Bmi1 expression would blunt neural 
sphere formation. Transdifferentiation was performed 
in the presence of oxysterol and/or purmorphamine to 
induce the transdifferentiation of MEFs into NSC-like 
cells. The formation of neurospheres and reprogram-
ming-related gene expression were significantly altered 
by the knock down of Bmi1 (Figure 5A-5C). Moreover, 
when cells treated with both oxysterol and purmor-
phamine were transduced with Oct4 in the presence of 
Bmi1 siRNA, the formation of Nanog-positive colonies 
was significantly decreased compared to control (Figure 5D).
We next tested the combination of oxysterol and Oct4 
on the reprogramming of tail-tip fibroblasts (TTFs) from 
10-week-old male mice (hereafter designated as OxyO-
iPS-TTF cells) and established two independent iPS 
cell lines. These cells were very similar to ES cells with 
an identical differentiation potential (Supplementary 
information, Figure S7). Growth rates and hierarchial 
clustering analysis of the global gene expression profiles 
showed that 1F (Oct4) and 2F (Oct4 and Bmi1) iPS cells 
clustered close to mES cells and were distinct from the 
parental MEFs and Bmi1-transduced neurospheres (Sup-
plementary information, Tables S1-S2 and Supplemen-
tary information, Figure S8). The chromosomal stability 
of 1F and 2F iPS cells was confirmed by metaphase 
spread (Supplementary information, Figure S9). Taken 
together, these results show that Bmi1 promotes iPS cell 
generation from fibroblasts; Bmi1 likely has dual effects 
on iPS cell generation from fibroblasts, by both suppress-
ing p16Ink4a and p19Arf and augmenting Sox2 and N-Myc 
(Figure 5E).
Discussion
In summary, our data support two main conclusions. 
First, Bmi1 can replace Sox2, Klf4, and C-Myc during 
reprogramming and enhances the reprogramming effi-
ciency of mouse fibroblasts infected with Oct4 and Sox2. 
This suggests that not only p16Ink4a and p19Arf [1-4, 6], 
but also Sox2 and C-Myc [17-19, 24] are rate-limiting 
determinants in the reprogramming process. The second 
conclusion relates to the number of factors applied to 
somatic cells for iPS cell generation. We demonstrated 
previously that mouse and human NSCs, which express 
endogenous Sox2, can be reprogrammed with Oct4 alone 
[17, 18]. Here, we expand upon these results by showing 
that Oct4, together with Bmi1 or activators of the Shh 
signaling pathway (Shh, oxysterol, and purmorphamine 
in this study), is sufficient for the generation of iPS cells 
from mouse embryonic and adult fibroblasts. This is es-
pecially crucial because adult fibroblasts do not express 
Sox2. This study, together with others is an important 
step forward in defining the critical determinants for the 
generation of iPS cells from differentiated fibroblasts 
[25-27]. Future studies will determine if we can combine 
our direct reprogramming procedure with small molecule 
compounds to activate endogenous expression of Oct4, 
knock down Oct4-specific suppressor(s), or achieve 
reprogramming with Oct4 recombinant protein alone.
Materials and Methods
Generation of 4F and 2F iPS cells
pBabe-based retroviral vectors encoding Oct4, Sox2, Klf4, or 
C-Myc (from Gou Young Koh), and Bmi1 (from Goberdhan P. 
Dimri) were transfected into PT67 amphotropic packaging cells 
(Clontech) using Turbofect (Fermentas) according to the manu-
facturer’s protocol. The cells were subjected to drug selection 
with 3 µg/ml puromycin (Bmi1, Klf4 and C-Myc) for 4 days or 1 
000 ng/ml G418 (Sox2 and Oct4) for 14 days. The viruses were 
collected after 24 h and filtered through a 0.45-µm filter before 
transduction. Induction of iPS cells was performed as described 
previously [24] with some modification. In brief, MEF cells (2 × 
105) were seeded in one well of a six-well plate and 2 ml of each 
retroviral supernatant (Bmi1 and Oct4) was added to the cells in 
the presence of 6 µg/ml of polybrene (Sigma). Two days after the 
initial transduction, cells were subcultured on mitomycin C-treated 
CF1 mouse feeder layers and maintained in mES cell medium 
consisting of DMEM supplemented with 15% FBS (Hyclone), 
β-mercaptoethanol, 1% penicillin-streptomycin, and 1 000 units/
ml leukemia inhibitory factor (LIF; Millipore). ES and iPS cells 
were passaged every 3-5 days using 0.05% trypsin-EDTA and 
seeded at 2 × 105 cells/well in a six-well plate. The induction of 
dBO-iPS cells was performed in two steps. Generation of NSC-
like cells was achieved with MEFs infected with retroviruses 
containing Bmi1, as described previously [16], and these NSC-like 
cells were then further infected with retroviruses containing Oct4, 
as above. Two days after Oct4-transduction, cells were grown in 
mES-culture conditions as described above. For the quantification 
of transduction efficiency, we introduced GFP to MEF as above 
and more than 70% of cells expressed GFP. To quantify efficiency 
of iPS generation, total number of Nanog-positive colonies were 
counted and calculated as percentage of infected cell numbers, 
which was calculated as GFP+ cells [28].
Generation of 1F iPS cells
To induce ShO-, PO-, OxyO-iPS, and OxyO-iPS-TTF cells, 
cells were cultured in NSC medium [16] with either Shh (500 ng/
ml; R&D systems), purmorphamine (0.5, 1 µM; Calbiochem), 
or 25-hydroxycholesterol (oxysterol; 0.1, 0.5 µM; Sigma) for 1 
day. Next, retroviral supernatants (Oct4) in NSC medium con-
taining 6 µg/ml polybrene were added to the cells with Shh, 
purmorphamine, or oxysterol. A third round of transduction was 
performed and the cells were incubated for 2 days. Two days after 
the initial transduction, cells were transferred and grown on mi-
tomycin C-treated MEF layers in mES cell medium. For siRNA 
experiments, cells were transfected with lipofectamine RNAiMAX 
(Invitrogen). Bmi1 siRNAs and control siRNAs were purchased 
from Bioneer.
Reprogramming of fibroblast into iPSCs with Bmi1
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Microarray analysis
Total RNA from MEF, mES, and iPS cells was labeled with 
Cy3. Labeled RNA was hybridized to the Agilent mouse whole-
genome array (G4122F) according to the manufacturer’s instruc-
tions. Arrays were scanned with the G2565BA Microarray Scanner 
System (Agilent Technologies). All data normalization and gene 
selection was performed using GeneSpring GX 7.3 (Agilent Tech-
nologies) [24].
Bisulfite sequencing analysis
DNA from MEF, mES, and iPS cells was isolated using the 
Genomic DNA Purification Kit (Promega). DNA was prepared 
for bisulfite sequencing with the EpiTect Bisulfite Kit (QIAGEN). 
Treated DNA was used to amplify the sequences of interest. The 
primers used for promoter fragment amplification are listed in 
Supplementary information, Table S3. The resulting fragments 
were cloned using the pGEM-T Easy Vector (Promega) for se-
quencing and sequenced with T7 forward and SP6 reverse primers.
ChIP assay
The ChIP assay was performed on MEFs, ES cells, and iPS 
cells using the EZ ChIP Kit (Millipore) according to the manufac-
turer’s instructions. Anti-acetyl H3 and anti-dimethyl K9 H3 an-
tibodies were used in this experiment. PCR primers used for real-
time PCR are listed in Supplementary information, Table S3.
Differentiation of iPS cells
iPS cells were examined by the in-vitro differentiation of EBs. 
iPS cells were trypsinized and single cells were cultured in suspen-
sion with EB medium without LIF for 7 days, and EBs were then 
replated onto 0.1% gelatin-coated plates. Spontaneous differentia-
tion was examined by immunostaining and RT-PCR for represen-
tative lineage-specific markers with the indicated antibodies and 
primers at various timepoints (5-7 days).
Teratoma formation
iPS cells (1 × 106/mouse) were injected under the kidney cap-
sule or subcutaneously into the dorsal flank of nude mice. Eight 
to ten weeks later, the mice developed teratomas, which were re-
moved, immediately rinsed with PBS, fixed in 10% formalin, and 
embedded in paraffin. Tissue sections 5-6 µm thick were cut and 
processed for hematoxylin-eosin staining.
Chimera formation and germline transmission
Four- to five-week-old female mice (C57BL/6) were induced to 
superovulate by intraperitoneal injection of 7.5 IU PMSG followed 
48 h later by intraperitoneal injection of 7.5 IU hCG and mated 
with a stud male mouse (C57BL/6). Blastocysts were collected 
3.5 days after vaginal plug check and flushing in H-CZB medium. 
Approximately 10 iPS cells then were expelled from the injection 
pipette against the inner cell mass of the blastocyst. Injected blas-
tocysts were transferred into the uterine horn of 2.5 days post co-
itum (dpc) pseudopregnant CD1 female mice that had been mated 
with vasectomized male mice. Chimerism was ascertained by the 
contribution rate of albino coat color (from iPS cells) in black host 
pups. High-contribution chimeras were mated with C57BL/6 mice 
to test for germline transmission.
Statistical analysis
Data were analyzed by analysis of variants using the general 
linear model procedures of the Statistical Analysis System (SAS, 
9.13 PACKAGE). Data were expressed as the means ± SD. P < 0.05 
was considered significant.
Accession codes
Gene Expression Omnibus (GEO): GSE24208
Further details and other methods can be found in the supple-
mentary information, Data S1.
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